Highly skilled physician scientist with 15 years of academic experience achieving patent, grant support and publications as well as long record of graduate and postgraduate student mentoring.
My research objective was to find an efficient stem cell therapy for Duchene Muscular Dystrophy through the creation of chimeric cells, created via ex-vivo PEG fusion of healthy and DMD affected myoblasts and mesenchymal stem cell. The two-year research project started from in vitro chimeric cell creation and analysis through preclinical administration-route testing in mdx/scid mice and resulted in three publication and ongoing grant support.
My work consisted in:
My goal was to complete pre-clinical testing of Mesenchymal Stem Cells as immunomodulators in an allogeneic organ transplant.· The non-human primate kidney transplant study highlighted that MSC immunomodulation is strongly influenced by recipient immune activation state. My research interest were also focused on the effect of MSC in enhancing wound healing and the possible mediators and molecular pathways involved, resulting in publications and numerous poster presentations.
Moreover, my work role included:
My research project , under the supervision of PI: Prof . Amelia Bartholomew, focused on testing efficacy of MSCs as immunomodulators in prolonging allogeneic organ transplant survival in mice. Results of this project granted the support for an R01 multicenter non-human preclinical study.
Moreover, my work role included:
Pursued independent and complementary research interests in detecting transplanted pancreatic islets and stem cells by MRI under the supervision of PI: Prof. Biancamaria Longoni, Prof. Franco Mosca, resulting in manuscript and numerous poster presentations.
https://www.ncbi.nlm.nih.gov/myncbi/1dg6xddwv0HAa/bibliography/public/
1. Malik M, Siemionow M, Cwykiel J, Heydemann A, Garcia-Martinez J, Siemionow K, Szilagyi E. Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy.
Postepy Kardiol Interwencyjnej. 2022 Dec;18(4):399-406.
2. Siemionow M, Szilagyi E, Cwykiel J, Domaszewska-Szostek A, Heydemann A, Garcia-Martinez J, Siemionow K. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model. Stem Cells Dev. 2021 Feb;30(4):190-202.
3. Carbonero F, Mayta A, Bolea M, Yu JZ, Lindeblad M, Lyubimov A, Neri F, Szilagyi E, Smith B, Halliday L, Bartholomew A. Specific Members of the Gut Microbiota are Reliable Biomarkers of Irradiation Intensity and Lethality in Large Animal Models of Human Health. Radiat Res. 2019 Jan;191(1):107-121.
4. Carbonero F, Mayta-Apaza AC, Yu JZ, Lindeblad M, Lyubimov A, Neri F, Szilagyi E, Bartholomew A. A comparative analysis of gut microbiota disturbances in the Gottingen minipig and rhesus macaque models of acute radiation syndrome following bioequivalent radiation exposures. Radiat Environ Biophys. 2018 Nov;57(4):419-426.
5. Siemionow M, Cwykiel J, Heydemann A, Garcia J, Marchese E, Siemionow K, Szilagyi E. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy. Stem Cell Rev Rep. 2018 Jun;14(3):370-384.
6. Siemionow M, Cwykiel J, Heydemann A, Garcia-Martinez J, Siemionow K, Szilagyi E. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy. Stem Cell Rev Rep. 2018 Apr;14(2):189-199.
7. Yu JZ, Lindeblad M, Lyubimov A, Neri F, Smith B, Szilagyi E, Halliday L, MacVittie T, Nanda J, Bartholomew A. Response to the "Letter to the Editor" by Dant, Stricklin and Millage on our Article: "Subject-Based versus Population- Based Care after Radiation Exposure". Radiat Res. 2016 Sep;186(3):323.
10. Lee S, Szilagyi E, Chen L, Premanand K, Dipietro LA, Ennis W, Bartholomew AM. Activated mesenchymal stem cells increase wound tensile strength in aged mouse model via macrophages. J Surg Res. 2012 May 29.
11. Longoni B, Szilàgyi E, Puviani L, Mazzanti B, Tripodi S, Caselli C, Paoli G, Urbani S, Quaranta P, Antonini S, Cintorino M, Saccardi R, Nardo B, Mosca F. Mesenchymal stem cell-based immunomodulation in allogeneic heterotopic heart-lung transplantation. Journal of Transplantation Technologies & Research. 2011
12. Szilagyi E, Mahmud N, and Bartholomew A. The Importance of Non-Human Primate Models for pre-clinical studies in Hematopoiesis. Allogenic Stem Cell Transplantation 2010 Contemporary Hematology, 2010, Book chapter, 767-787
13. Longoni B, Szilagyi E, Quaranta P, Paoli GT, Tripodi S, Urbani S, Mazzanti B, Rossi B, Fanci R, Demontis GC, Marzola P, Saccardi R, Cintorino M, Mosca F. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technol Ther. 2010 Jun; 12(6):435-46.
14. Marzola P, Longoni B, Szilagyi E, Merigo F, Nicolato E, Fiorini S, Paoli GT, Benati D, Mosca F, Sbarbati A. In vivo visualization of transplanted pancreatic islets by MRI: comparison between in vivo, histological and electron microscopy findings. Contrast Media Mol Imaging. 2009 May-Jun;4(3):13542
15. Bartholomew A, Polchert D, Szilagyi E, Douglas GW, Kenyon N. Mesenchymes stem cells in the induction of transplantation tolerance. Transplantation. 2009 May 15; 87(9 Suppl): S55-7. Review.